Evaro secures $25m in Series A funding led by AlbionVC to expand its embedded healthcare platform
AlbionVC led the Series A round for the healthcare-as-a-service provider, with backing from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI.
≈ £18.1M at $1 = £0.7232 on 27 Jan 2026
Evaro provides a licensed healthcare-as-a-service platform that allows consumer brands to embed clinical services such as consultations and prescriptions into their own applications.
Evaro has raised $25m in a Series A round led by AlbionVC, with additional participation from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI. The company intends to direct the capital towards expanding beyond men's and women's health into longevity and advanced diagnostics, forming partnerships with further brands and organisations, and refining its integration technology.
Founded in 2018, Evaro provides an API-first platform that enables consumer brands to embed regulated clinical services directly into their applications. The company holds multiple regulatory approvals and has delivered care to two million patients to date.
Use of funds
- 01Continue product development
- 02Expand into international markets
